Literature DB >> 26328886

MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression.

Hongmou Yuan1, Yanjun Gao1.   

Abstract

Osteosarcoma is a high-grade malignant bone neoplasm. Although the introduction of chemotherapy has reduced its mortality, >50% of patients develop chemoresistance and have an extremely poor prognosis due to pulmonary metastasis. Several molecular pathways contributing to osteosarcoma development and progression have recently been identified. Various studies have addressed the genes involved in the metastasis of osteosarcoma. However, the highly complex molecular mechanisms of metastasis remain to be elucidated. Recent studies have emphasized causative links between aberrant microRNA expression patterns and osteosarcoma progression. miR-1908 is dysregulated in certain human types of cancer. The expression pattern, clinical significance and biological role of miR-1908 in osteosarcoma, however, remain largely undefined. In the present study, we showed that miR-1908 was markedly upregulated in osteosarcoma cells and tissues compared with normal bone tissues using RT-qPCR. miR-1908 upregulation in osteosarcoma tissues was significantly associated with cell proliferation, invasion, advanced TNM stage and tumor growth. Both gain- and loss-of-function studies showed that miR-1908 markedly increased the ability of osteosarcoma cells to proliferate and to invade through Matrigel in vitro. Analyses using mouse xenograft model revealed that xenografts of miR-1908 stable-expressing osteosarcoma cells exhibited a significant increase in tumor volume and weight, compared with the control group. Subsequent investigations revealed that miR-1908 directly inhibited the expression of phosphatase and tensin homolog deleted on chromosome ten (PTEN). Using a luciferase reporter carrying the 3'-untranslated region (3'-UTR) of PTEN, we identified PTEN as a direct target of miR-1908. Collectively, the results showed that, miR-1908 promotes proliferation and invasion of osteosarcoma cells by repressing PTEN expression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26328886     DOI: 10.3892/or.2015.4242

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  13 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Low expression of microRNA-1908 predicts a poor prognosis for patients with ovarian cancer.

Authors:  Changcai Teng; Hong Zheng
Journal:  Oncol Lett       Date:  2017-08-03       Impact factor: 2.967

3.  Novel Germline PTEN Mutation Associated with Cowden Syndrome and Osteosarcoma.

Authors:  Christian Lopez; Mohammad Abuel-Haija; Luis Pena; Domenico Coppola
Journal:  Cancer Genomics Proteomics       Date:  2018 Mar-Apr       Impact factor: 4.069

4.  MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway.

Authors:  Chen Lv; Yuehan Hao; Guanjun Tu
Journal:  Tumour Biol       Date:  2016-01-16

Review 5.  Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.

Authors:  Dinh-Duc Nguyen; Suhwan Chang
Journal:  Int J Mol Sci       Date:  2017-12-27       Impact factor: 5.923

6.  miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis.

Authors:  Zhi Chai; Huijie Fan; Yanyan Li; Lijuan Song; Xiaoming Jin; Jiezhong Yu; Yanhua Li; Cungen Ma; Ran Zhou
Journal:  Oncol Rep       Date:  2017-09-26       Impact factor: 3.906

7.  The miR-1908/SRM regulatory axis contributes to extracellular vesicle secretion in prostate cancer.

Authors:  Fumihiko Urabe; Nobuyoshi Kosaka; Yurika Sawa; Kagenori Ito; Takahiro Kimura; Shin Egawa; Takahiro Ochiya; Yusuke Yamamoto
Journal:  Cancer Sci       Date:  2020-07-18       Impact factor: 6.716

8.  MiRNA-221 from tissue may predict the prognosis of patients with osteosarcoma.

Authors:  Ningji Gong; Mingzhi Gong
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.

Authors:  Jun Shi; Daijuan Huang; Gao Zhang; Feng Zhao; Lin Yang
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

Review 10.  Osteosarcoma and Metastasis.

Authors:  Gaohong Sheng; Yuan Gao; Yong Yang; Hua Wu
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.